Boditech Med Inc. (KOSDAQ:206640)
 13,570
 -20 (-0.15%)
  Oct 31, 2025, 3:30 PM KST
Boditech Med Market Cap
Boditech Med has a market cap or net worth of 296.03 billion as of October 31, 2025. Its market cap has decreased by -19.33% in one year.
Market Cap 
 296.03B
Enterprise Value 
 259.57B
Revenue 
 149.40B
Ranking 
 n/a
PE Ratio 
 11.63
Stock Price 
13,570.00
Market Cap Chart
Since September 1, 2015, Boditech Med's market cap has increased from 28.15B to 296.03B, an increase of 951.56%. That is a compound annual growth rate of 26.03%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 296.03B | -19.72% | 
| Dec 30, 2024 | 368.76B | -18.12% | 
| Dec 28, 2023 | 450.36B | 100.01% | 
| Dec 29, 2022 | 225.17B | -41.09% | 
| Dec 30, 2021 | 382.21B | -29.94% | 
| Dec 30, 2020 | 545.55B | 146.19% | 
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro | 
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro | 
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Samsung Biologics | 87.69T | 
| Celltrion | 38.90T | 
| ALTEOGEN | 24.95T | 
| SK Biopharmaceuticals | 8.97T | 
| Yuhan | 8.77T | 
| HLB Co., Ltd. | 6.30T | 
| Peptron | 6.18T | 
| PharmaResearch | 5.36T |